HIF1A and neoplasm: Moreover, although inhibition of HIF1α, HDAC1, or EZH2 in immune cells can restore immune cytotoxicity, it also paradoxically induces PD-L1 and PD-L2 expression in tumor cells that in turn could weaken anticancer immunity.